Intuitive Surgical Shares Rise Amid Analyst Support Despite J&J Competition
Intuitive Surgical's shares rebounded following initial declines triggered by Johnson & Johnson securing authorization for its Ottava surgical robot. The stock gained traction after two analysts expressed confidence in Intuitive Surgical’s market position and long-term prospects, despite the competitive threat from J&J. Analysts highlighted continued demand for minimally invasive robotic surgery solutions as a key driver of growth for Intuitive Surgical. They also noted that while competition is intensifying, Intuitive remains dominant due to its established ecosystem and surgeon training programs. The market reaction reflects cautious optimism about the company's ability to maintain leadership in surgical robotics despite new entrants like Johnson & Johnson.
Topics: analyst support Intuitive Surgical Johnson & Johnson surgical robots